InvestSMART

ECS Botanics Holdings Ltd (ASX: ECS) - Announcements

- Current share price for ECS : $0.005

ASX company news and announcements for ECS Botanics Holdings Ltd (ECS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ECS Botanics Holdings Ltd (ECS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ECS Botanics Holdings Ltd (ECS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ECS Botanics Holdings Ltd (ECS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8 Q3 FY26 Investor Webinar 1 May 2026 2:07PM $0.005 $0.005 fallen by 0%
$8 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2026 8:14AM $0.006 $0.005 fallen by 16.67%
$8 ECS to Present at NWR Healthcare Conference - Thu 26 Mar 19 Mar 2026 9:43AM $0.006 $0.005 fallen by 9.09%
$8 HY FY26 Results Presentation 4 Mar 2026 10:56AM $0.006 $0.005 fallen by 16.67%
$8 Notification of cessation of securities - ECS 3 Mar 2026 1:07PM $0.006 $0.005 fallen by 16.67%
$8 H1 FY26 Results-Return to Profitability & Positive Cashflow 27 Feb 2026 12:02PM $0.006 $0.005 fallen by 16.67%
$8 Half Yearly Report and Accounts 27 Feb 2026 12:01PM $0.006 $0.005 fallen by 16.67%
$8 ECS Enters German Distribution Partnership with OzSun 11 Feb 2026 9:57AM $0.005 $0.005 fallen by 0%
$8 Security Class Reinstatement to Quotation - ECSO 30 Jan 2026 7:01PM $0.006 $0.005 fallen by 16.67%
$8 Change of Director's Interest Notice (X2) 30 Jan 2026 4:36PM $0.006 $0.005 fallen by 16.67%
$8 ECSO Top 20 29 Jan 2026 6:13PM $0.006 $0.005 fallen by 16.67%
$8 ECSO Distribution Schedule 29 Jan 2026 6:13PM $0.006 $0.005 fallen by 16.67%
$8 Application for quotation of securities - ECS 29 Jan 2026 6:12PM $0.006 $0.005 fallen by 16.67%
$8 Security Class Suspension from Quotation - ECSO 29 Jan 2026 12:13PM $0.006 $0.005 fallen by 9.09%
$8 Notification regarding unquoted securities - ECS 20 Jan 2026 5:44PM $0.007 $0.005 fallen by 28.57%
$8 Update - Proposed issue of securities - ECS 16 Jan 2026 4:11PM $0.007 $0.005 fallen by 28.57%
$8 Proposed issue of securities - ECS 16 Jan 2026 1:32PM $0.007 $0.005 fallen by 28.57%
$8 Prospectus - Loyalty Options 14 Jan 2026 4:52PM $0.007 $0.005 fallen by 28.57%
$8 Quarterly Activities/Appendix 4C Cash Flow Report 14 Jan 2026 8:35AM $0.006 $0.005 fallen by 16.67%
$8 Results of Meeting 8 Jan 2026 12:54PM $0.006 $0.005 fallen by 16.67%
$8 ECS BOTANICS ADVANCES PREPARATIONS FOR US MARKET ENTRY 16 Dec 2025 9:30AM $0.007 $0.005 fallen by 28.57%
$8 ECS launches Woman Health Brand 4 Dec 2025 9:16AM $0.006 $0.005 fallen by 9.09%
$8 Letter to Shareholders 1 Dec 2025 4:02PM $0.005 $0.005 fallen by 0%
$8 Notice of Extraordinary General Meeting/Proxy Form 1 Dec 2025 3:57PM $0.005 $0.005 fallen by 0%
$8 ECS Launches Sugar-Free Gummies as B2C Sales Surpass 60% 21 Nov 2025 8:20AM $0.005 $0.005 fallen by 0%

26 - 50 of 425 results

Page 2 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.